CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Namdar, Afshin ^a   Koleva, Petya ^a   Shahbaz, Shima ^a   Strom, Stacy ^b   Gerdts, Volker ^b,c   Elahi, Shokrollah ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CD71 ANTIGEN; CYTOKINE; LEUKOCYTE ANTIGEN; TRANSFERRIN RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BORDETELLA PERTUSSIS; ERYTHROID CELL; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LUNG; MALE; METABOLISM; MICROBIOLOGY; MOUSE; NEWBORN; PERTUSSIS; T LYMPHOCYTE SUBPOPULATION;

ADAPTIVE IMMUNITY; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; BIOMARKERS; BORDETELLA PERTUSSIS; CYTOKINES; ERYTHROID CELLS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOMODULATION; IMMUNOPHENOTYPING; LUNG; MALE; MICE; RECEPTORS, TRANSFERRIN; T-LYMPHOCYTE SUBSETS; WHOOPING COUGH;

EID: 85044632817     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07938-7     Document Type: Article

References (50)

1. The State of the world’s children, 2007: women and children: the double dividend of gender equality. Choice: Current Reviews for Academic Libraries 45, 365–365 (2007)
2. Mphatswe, W. et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. Aids 21, 1253–1261, doi:10.1097/Qad.0b013e3281a3bec2 (2007)
3. Muenchhoff, M., Prendergast, A. J. & Goulder, P. J. Immunity to HIV in Early Life. Frontiers in immunology 5, 391, doi:10.3389/fimmu.2014.00391 (2014)
4. Cherpes, T. L., Matthews, D. B. & Maryak, S. A. Neonatal herpes simplex virus infection. Clin Obstet Gynecol 55, 938–944, doi:10.1097/GRF.0b013e31827146a7 (2012)
5. Adkins, B., Leclerc, C. & Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nature reviews. Immunology 4, 553–564, doi:10.1038/nri1394 (2004)
6. Adkins, B. Development of neonatal Th1/Th2 function. Int Rev Immunol 19, 157–171 (2000)
7. Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 282, 20143085, doi:10.1098/rspb.2014.3085 (2015)
8. Liu, L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161, doi:10.1016/S0140-6736(12)60560-1 (2012)
9. Forsthuber, T., Yip, H. C. & Lehmann, P. V. Induction of TH1 and TH2 immunity in neonatal mice. Science 271, 1728–1730 (1996)
10. Ridge, J. P., Fuchs, E. J. & Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723–1726 (1996)
11. Sarzotti, M., Robbins, D. S. & Hoffman, P. M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271, 1726–1728 (1996)
12. Elahi, S. et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature 504, 158–162, doi:10.1038/nature12675 (2013)
13. Elahi, S. et al. Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun 73, 3636–3645, doi:10.1128/IAI.73.6.3636-3645.2005 (2005)
14. Elahi, S. et al. Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs. The Journal of infectious diseases 198, 384–392, doi:10.1086/589713 (2008)
15. Guiso, N. Bordetella pertussis: why is it still circulating. J Infect 68(Suppl 1), S119–124, doi:10.1016/j.jinf.2013.09.022 (2014)
16. Hartzell, J. D. & Blaylock, J. M. Whooping cough in 2014 and beyond: an update and review. Chest 146, 205–214, doi:10.1378/chest.13-2942 (2014)
17. CDC. Pertussis–United States, 1997–2000. MMWR Morb Mortal Wkly Rep 51, 73–76 (2002)
18. CDC. Pertussis deaths–United States, 2000. MMWR Morb Mortal Wkly Rep 51, 616–618 (2002)
19. Healy, C. M. et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 190, 335–340 (2004)
20. Greco, D. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334, 341–348 (1996)
21. Gustafsson, L., Hallander, H. O., Olin, P., Reizenstein, E. & Storsaeter, J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334, 349–355 (1996)
22. Halperin, S. A., Issekutz, T. B. & Kasina, A. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin. J Infect Dis 163, 355–361 (1991)
23. Mountzouros, K. T., Kimura, A. & Cowell, J. L. A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis. Infect Immun 60, 5316–5318 (1992)
24. Redhead, K., Watkins, J., Barnard, A. & Mills, K. H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 61, 3190–3198 (1993)
25. Shahin, R. D., Brennan, M. J., Li, Z. M., Meade, B. D. & Manclark, C. R. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med 171, 63–73 (1990)
26. Shahin, R. D., Hamel, J., Leef, M. F. & Brodeur, B. R. Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun 62, 722–725 (1994)
27. Mahon, B. P., Brady, M. T. & Mills, K. H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis 181, 2087–2091 (2000)
28. Mills, K. H., Barnard, A., Watkins, J. & Redhead, K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 61, 399–410 (1993)
29. Mills, K. H., Ryan, M., Ryan, E. & Mahon, B. P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 66, 594–602 (1998)
30. Ausiello, C. M. et al. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev Biol Stand 89, 315–320 (1997)
31. Barbic, J., Leef, M. F., Burns, D. L. & Shahin, R. D. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun 65, 4904–4908 (1997)
32. Mahon, B. P., Sheahan, B. J., Griffin, F., Murphy, G. & Mills, K. H. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med 186, 1843–1851 (1997)
33. Ross, P. J. et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS pathogens 9, e1003264, doi:10.1371/journal.ppat.1003264 (2013)
34. Garlapati, S. et al. Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis. Vaccine 29, 6540–6548 (2011)
35. Polewicz, M. et al. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 31, 3148–3155, doi:10.1016/j.vaccine.2013.05.008 (2013)
36. Brady, M. T., Mahon, B. P. & Mills, K. H. Pertussis infection and vaccination induces Th1 cells. Immunology today 19, 534 (1998)
37. Higgs, R., Higgins, S. C., Ross, P. J. & Mills, K. H. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal immunology 5, 485–500, doi:10.1038/mi.2012.54 (2012)
38. Dunne, A. et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. Journal of immunology 185, 1711–1719, doi:10.4049/jimmunol.1000105 (2010)
39. Higgins, S. C., Jarnicki, A. G., Lavelle, E. C. & Mills, K. H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. Journal of immunology 177, 7980–7989 (2006)
40. Warfel, J. M. & Merkel, T. J. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal immunology 6, 787–796, doi:10.1038/mi.2012.117 (2013)
41. Ghoreschi, K., Laurence, A., Yang, X. P., Hirahara, K. & O’Shea, J. J. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 32, 395–401, doi:10.1016/j.it.2011.06.007 (2011)
42. Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514–518, doi:10.1038/nature10957 (2012)
43. Willems, F., Vollstedt, S. & Suter, M. Phenotype and function of neonatal DC. European journal of immunology 39, 26–35, doi:10.1002/eji.200838391 (2009)
44. De Wit, D. et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 21, 277–281 (2003)
45. Mills, K. H. G., Ryan, M., Ryan, E. & Mahon, B. P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infection and Immunity 66, 594–602 (1998)
46. Basha, S., Surendran, N. & Pichichero, M. Immune responses in neonates. Expert Rev Clin Immunol 10, 1171–1184, doi:10.1586/1744666X.2014.942288 (2014)
47. Elahi, S. et al. c-di-GMP enhances protective innate immunity in a murine model of pertussis. PloS one 9, e109778, doi:10.1371/journal.pone.0109778 (2014)
48. Elahi, S. et al. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nature medicine 17, 989–995, doi:10.1038/nm.2422 (2011)
49. Elahi, S., Weiss, R. H. & Merani, S. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. Aids 30, 171–183, doi:10.1097/QAD.0000000000000917 (2016)
50. Ren, S. W. et al. Selection of housekeeping genes for use in quantitative reverse transcription PCR assays on the murine cornea. Mol Vis 16, 1076–1086 (2010)